Alexandra Pearce has been appointed head of regulatory affairs, effective 21 May, by Abivax SA which is developing a treatment for HIV. In previous positions, she has led global registrations for products across a variety of therapeutic areas. She joins Abivax from Viramal Ltd where she was chief operations officer and head of regulatory affairs. Dr Pearce received her PhD in biotechnology from the Open University in London, UK.
Abivax announced the appointment on 9 April 2018.
Copyright 2018 Evernow Publishing Ltd.